ISPOR, the professional society for health economics and outcomes research, explored the possibility of health technology assessment in the United States this morning at its ISPOR 2019.
ISPOR, the professional society for health economics and outcomes research (HEOR), held a session for its Women in HEOR initiative yesterday late afternoon at its ISPOR 2019 annual conference in New Orleans, LA, USA.
ISPOR, the professional society for health economics and outcomes research (HEOR), examined how real-world evidence can be improved with patient-provided information this afternoon at its ISPOR 2019 annual conference.
ISPOR, the professional society for health economics and outcomes research (HEOR), explored the future of HEOR for the 2020s this afternoon at its ISPOR 2019 annual conference.
ISPOR, the professional society for health economics and outcomes research, started the day with the second plenary session of its ISPOR 2019 annual conference with, “Medical Device Innovation and Regulation: Turbocharged for Success?"
ISPOR, the professional society for health economics and outcomes research (HEOR), examined the past 20 years of scientific publications in HEOR this afternoon at its ISPOR 2019 annual conference with the spotlight session issue panel [SP2], “Back to the Future in Value in Health.”
ISPOR, the professional society for health economics and outcomes research (HEOR), explored the issue of orphan drug approvals and how they challenge health plans at its ISPOR 2019 annual conference this morning.
ISPOR, the professional society for health economics and outcomes research (HEOR), opened its ISPOR 2019 annual conference this morning with a keynote and first plenary, “The Dawn of Disruption in the Health Sector: Will Innovative Technologies Require Innovative Thinking?”
ISPOR—the professional society for health economics and outcomes research (HEOR)—honored global leaders in the field at its Annual Awards Banquet last night.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a special 20th anniversary issue that reflects on how “value” has been defined, measured, and debated in the journal for the past two decades.
ISPOR—the professional society for health economics and outcomes research (HEOR)—released the final program and speakers for its upcoming ISPOR 2019 annual conference scheduled for May 18-22, 2019 in New Orleans, LA, USA.
ISPOR—the professional society for health economics and outcomes research, today released its 2018 Annual Report. The report highlights a very productive year with Society achieving a number of notable milestones.
Value in Health announced the publication of new research showing that consideration is rarely given to the health economic analysis of adaptive clinical trials. As a result, opportunities to use health economic outcomes in the design and analysis of adaptive trials are being missed.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a new report introducing Bayesian networks, a knowledge representation and machine-learning tool for risk estimation in medical science.
ISPOR announced plenary sessions and speakers for ISPOR 2019. The conference will be held May 18-22, 2019 in New Orleans, LA, USA and will focus on the theme, “Rapid. Disruptive. Innovative: A New Era in Health Economics and Outcomes Research.”
ISPOR announced today the honorees for its 2019 Health Economics and Outcomes Research Scientific and Leadership Awards.
ISPOR announced today the publication of new recommendations from the Health State Utilities in Cost-Effectiveness Models ISPOR Good Practices for Outcomes Research Task Force.
Value in Health announced the publication of new research showing that pharmaceutical risk-sharing arrangements can mitigate uncertainty around the budget impact of drugs, but only when the type of arrangement matches the setting and type of uncertainty.
Value in Health announced today the publication of new research showing that Canadians believe drug coverage decision makers should prioritize safety, effectiveness, and strong evidence.
ISPOR—the professional society for health economics and outcomes research, announced a new webinar on the "ISPOR 2019 Top 10 HEOR Trends" report. The free webinar will be held on March 22, 2019 and is open to both ISPOR members and non-members.
Value in Health, the official journal of ISPOR, announced the publication of new research showing that the use of cost-effectiveness opinions issued by the French National Health Authority improved the information available to support the pricing decisions for new hepatitis C drugs.
Value in Health, the official journal of ISPOR, announced the publication of new research suggesting that there is no standardized method to measure adherence to multiple medications (MMA), nor is there agreement between researchers on how to use a specific existing measure to calculate MMA.
Value in Health, the official journal of ISPOR, announced the publication of new research showing that the use of financial incentives to encourage engagement with tobacco quit line treatment is a cost-effective option to enhance smoking cessation rates for low-income smokers.
ISPOR announced the publication of a scoping review showing that “medical nutrition” terminology is not consistently defined, relevant European and US regulations are infrequently cited, and economic evaluations are infrequently conducted. The report was published in Value in Health.
ISPOR—professional society for health economics and outcomes research—announced a new regional conference, ISPOR Warsaw 2019, scheduled for 27-28 March 2019 in Warsaw, Poland.
ISPOR, the professional society for health economics and outcomes research, has been awarded multiple AVA Digital Awards in recognition of several digital campaigns.
ISPOR—the professional society for health economics and outcomes research—announced today the publication of the first report in 20 years to comprehensively synthesize good practices in health technology assessment.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a series of papers that reflect the current research focus and interests of the EuroQol Group.
SPOR—the professional society for health economics and outcomes research (HEOR), announced today the release of its 2019 Top 10 HEOR Trends report. For the second year, based on a survey of its members, the Society has identified the top 10 HEOR trends that will shape the field in the near future.
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research describing a method to predict generic entry of top-selling drugs and a formal assessment of its accuracy.
Value in Health, the official journal of ISPOR, announced today the publication of new research finding that of 20 quality of life (QoL) instruments tested, only two (KIDSCREEN and KINDL) are recommended for service providers to measure the QoL of children with a disability.
Value in Health Regional Issues, the regionally focused online journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a series of 4 articles describing current drug policy in Estonia, Romania, Greece, and the Russian Federation.
Value in Health, the official journal of ISPOR, announced today the publication of new research showing that the lowest priced generic drugs are at a substantially elevated risk of experiencing a drug shortage, and that periods of drug shortages are associated with only modest increases in drug prices.
Value in Health announced the publication of new research showing that the Diabetes Medication System Rating Questionnaire and the Diabetes Medication System Rating Questionnaire-Short Form are the preferred survey instruments for measuring medication satisfaction in patients with type 2 diabetes using oral therapy in clinical trials.
ISPOR—the professional society for health economics and outcomes research, has received multiple MarCom Awards for its new organizational rebranding, newly redesigned website, and a number of other communications initiatives.
ISPOR CEO and Executive Director Nancy S. Bergwas recently honored with 3 Stevie Awards®. The Stevie Awards for Women in Business are the world’s top honors for female entrepreneurs, executives, employees, and the organizations they run.
ISPOR Europe 2018 concluded yesterday in Barcelona, Spain with record attendance. The Society had 5507 total attendees register for the event—the largest for any of its conferences to date.
ISPOR Europe 2018 session addresses challenges to open science, including data sharing, replication, and robustness of evidence from real-world data.
The third plenary of ISPOR Europe 2018 focused on the issue of budget impact and expenditure caps in healthcare.
A session at ISPOR Europe 2018 reported on the progress on its ISPOR Health Economics and Outcomes Research Competencies Framework™ initiative.
A session at ISPOR Europe 2018 explored how patient engagement is transforming healthcare.
ISPOR, the professional society for health economics and outcomes research (HEOR), presented a number of honorees with its annual HEOR awards this morning at ISPOR Europe 2018.
A session at ISPOR Europe 2018 explored the issue of valuing a cure in healthcare.
The second plenary at ISPOR Europe 2018, “Pharmaceutical Pricing: The Many Faces of Fairness,” sought to define “fair” in the context of pharmaceutical pricing.
ISPOR Europe 2018 session explored the evolving European Union policy landscape with panelists discussing if Europe is on the right path to improve outcomes research of medical devices.
ISPOR Europe 2018 session explored health technology assessment value-based pricing versus WHO fair pricing to assess which approach best delivers universal health coverage.
A session, “Healthcare X.0: Digital Technologies and Creation of Value,” at ISPOR Europe 2018 explored how digital technologies are creating the next generation healthcare system in Europe and beyond.
ISPOR Europe 2018 session, “Will Machines Soon Make Health Economists Obsolete?” explored the impact of machine learning on health economics.
ISPOR Europe 2018 opened this morning with its first plenary, “Joint Assessment of Relative Effectiveness: ‘Trick or Treat’ for Decision Makers in the EU Member States,” a session on the impact of the European Commission’s Draft Regulation on health technology assessment.
ISPOR, the professional society for health economics and outcomes research (HEOR), released the final program and speakers for its upcoming ISPOR Europe 2018 conference scheduled for 10-14 November in Barcelona, Spain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right